SI2068930T1 - Compositions and methods using anti-cs1 antibodies to treat multiple myeloma - Google Patents
Compositions and methods using anti-cs1 antibodies to treat multiple myelomaInfo
- Publication number
- SI2068930T1 SI2068930T1 SI200731073T SI200731073T SI2068930T1 SI 2068930 T1 SI2068930 T1 SI 2068930T1 SI 200731073 T SI200731073 T SI 200731073T SI 200731073 T SI200731073 T SI 200731073T SI 2068930 T1 SI2068930 T1 SI 2068930T1
- Authority
- SI
- Slovenia
- Prior art keywords
- antibodies
- compositions
- methods
- multiple myeloma
- treat multiple
- Prior art date
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83625006P | 2006-08-07 | 2006-08-07 | |
US85614406P | 2006-11-01 | 2006-11-01 | |
EP07840744A EP2068930B1 (en) | 2006-08-07 | 2007-08-07 | Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
PCT/US2007/075401 WO2008019376A2 (en) | 2006-08-07 | 2007-08-07 | Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2068930T1 true SI2068930T1 (en) | 2013-01-31 |
Family
ID=41104974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200731073T SI2068930T1 (en) | 2006-08-07 | 2007-08-07 | Compositions and methods using anti-cs1 antibodies to treat multiple myeloma |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN101534860B (en) |
SI (1) | SI2068930T1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102241773B (en) * | 2010-05-13 | 2014-05-14 | 四川大学 | Anti-myeloma cell polyclonal antibody and preparation method thereof |
CN102048743A (en) * | 2010-11-29 | 2011-05-11 | 周帆 | Medical combination for treating complications of multiple myeloma |
MY175418A (en) * | 2013-03-13 | 2020-06-24 | Sanofi Sa | Compositions comprising anti-cd38 antibodies and carfilzomib |
ES2886657T3 (en) * | 2015-06-29 | 2021-12-20 | Bristol Myers Squibb Co | Immunotherapeutic dosage regimens comprising pomalidomide and an anti-CS1 antibody for the treatment of cancer |
-
2007
- 2007-08-07 SI SI200731073T patent/SI2068930T1/en unknown
- 2007-08-07 CN CN200780035366.0A patent/CN101534860B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN101534860B (en) | 2013-03-27 |
CN101534860A (en) | 2009-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL196920A0 (en) | Compositions and methods using anti-csi antibodies to treat multiple myeloma | |
HRP20170347T1 (en) | Compositions and methods for use for antibodies against sclerostin | |
HUS1600043I1 (en) | Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies | |
EP2185201A4 (en) | Compositions and methods for crystallizing antibodies | |
AP2885A (en) | Methods and compositions for improving plant health | |
HK1145339A1 (en) | Methods and compositions for targeted integration | |
IL195619A0 (en) | Compositions and methods for joininig non-conjoined iumens | |
IL193920A0 (en) | Methods of treating lupus using cd4 antibodies | |
EP2219458A4 (en) | Compositions and methods for generating antibodies | |
HK1127294A1 (en) | Improved treatment of multiple myeloma | |
IL210097A0 (en) | Compositions and methods for treating unfluenza | |
EP2109673A4 (en) | Methods and compositions for enhanced protein expression and purification | |
EP2294199A4 (en) | Compositions and methods for improving plants | |
IL232011A0 (en) | Antibodies to egfl7 and methods for their use | |
GB0605247D0 (en) | Compositions and methods for immunisation | |
HK1129596A1 (en) | Methods and compositions for treating disease | |
SI2068930T1 (en) | Compositions and methods using anti-cs1 antibodies to treat multiple myeloma | |
ZA200807524B (en) | Methods of treating lupus using CD4 antibodies | |
EP2059122A4 (en) | Methods and compositions related to apobec-1 expression | |
ZA200807225B (en) | Antibodies to EGFL7 and methods for their use |